sequencing dual braf-mek inhibition and immunotherapy
Published 8 years ago • 1.8K plays • Length 9:43Download video MP4
Download video MP3
Similar videos
-
6:05
duration of dual braf-mek inhibition
-
6:39
questions about sequencing in braf-mutant melanoma
-
7:15
dual targeted or immunotherapy for braf-mutant melanoma
-
8:04
treatment sequencing in braf metastatic melanoma
-
8:47
braf/mek inhibitors in metastatic melanoma
-
1:30
dr. jason luke on sequencing targeted and immunotherapy agents in braf melanoma
-
7:01
dual-targeted therapy for braf-mutant melanoma
-
8:40
melanoma: braf/mek targeted therapy
-
1:33
dr. paul chapman on braf and mek inhibitor combination for advanced melanoma
-
2:45
immunotherapy vs braf/mek inhibitors in the adjvuant setting: is there a clear winner?
-
2:20
combination strategies: mek inhibition and immunotherapy in gist
-
1:28
jeffrey weber, md, phd: the impact of braf/mek inhibitors in melanoma
-
9:49
melanoma: nuances of braf/mek combinations in the front line
-
1:28
dr. puzanov on sequencing targeted therapy and immunotherapy in melanoma
-
6:22
braf and mek in melanoma
-
0:52
dr. kudchadkar on combining braf and mek inhibitors to treat melanoma
-
1:04
adverse events of braf and mek inhibitors
-
9:33
immunotherapy vs tkis in braf metastatic melanoma
-
1:19
dr. postow on braf and mek inhibitor combination studies in melanoma